Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)

被引：0
|
作者：
Lord H. [1 ,2 ]
机构：
[1] University of Montréal, Montréal, Que.
[2] Maisonneuve Rosemont, University of Montréal, Montréal, Que. HIT 2M4
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Sirolimus; Risedronate; Mycophenolate Mofetil; Graft Function; Darbepoetin Alfa;
D O I：
10.2165/00003495-200666002-00004
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
下载
收藏
页码：11 / 13
页数：2
相关论文
共 50 条
  • [41] Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers
    Rupprecht, Korbinian
    Schmidt, Christoph
    Raspe, Anne
    Schweda, Frank
    Shipkova, Maria
    Fischer, Wolfgang
    Bucher, Michael
    Kees, Frieder
    Faerber, Lothar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (10): : 1196 - 1201
  • [42] Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
    Yichen Jia
    Rulin Wang
    Long Li
    Ying Zhang
    Jiawei Li
    Jina Wang
    Xuanchuan Wang
    Guisheng Qi
    Ruiming Rong
    Ming Xu
    Tongyu Zhu
    BMC Pharmacology and Toxicology, 19
  • [43] Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: Conversion to enteric-coated mycophenolate sodium
    Calvo, N.
    Sanchez-Fructuoso, A. I.
    Conesa, J.
    Moreno, A.
    Barrientos, A.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2396 - 2397
  • [44] Enteric-coated mycophenolate sodium: an update
    Zhang, W.
    Ding, C.
    Zheng, S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 : 1 - 3
  • [45] Mycophenolate Mofetil and Enteric-Coated Mycophenolic Sodium: Are These Drugs Similarly Monitorable?
    Hougardy, J. -M.
    Maufort, L.
    Coussement, J.
    Cotton, F.
    Catalano, C.
    Kianda, M.
    Massart, A.
    Wissing, M.
    Abramowicz, D.
    TRANSPLANTATION, 2012, 94 (10) : 965 - 965
  • [46] Safety conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in children with stable renal transplant.
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Hallush
    Olandoski, Karen Previch
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 54 - 54
  • [47] Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients
    Massari, P
    Duro-Garcia, V
    Girón, F
    Hernández, E
    Juárez, F
    Castro, C
    Toledo, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 916 - 919
  • [48] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders
    Darji, P.
    Vijayaraghavan, R.
    Thiagarajan, C. M.
    Sharma, R. K.
    Subbarao, B.
    Pishardy, R.
    Dakshinamurthy, K. V.
    Vijaykumar, R.
    Abraham, G.
    Bhaskar, S.
    Agarwal, L.
    Shah, B.
    Abraham, A.
    John, M.
    Sampathkumar, K.
    Das, T.
    Umesh, L.
    Sundar, S.
    Ballal, H.
    Jasuja, S.
    Saxena, S.
    Saha, T. K.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2262 - 2267
  • [49] Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium
    Cofan, F.
    Rosich, E.
    Arias, M.
    Torregrosa, V.
    Oppenheimer, F.
    Campistol, J. M.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2179 - 2181
  • [50] Orthotopic Heart Transplant Recipient with Enteric-coated Mycophenolate Sodium (Myfortic) Induced Colitis
    Morris, Craig C.
    Stroud, Steven C.
    Golconda, Umamaheshwari
    Gregoire, Sharon A.
    Juneman, Elizabeth B.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21
12345